Alemtuzumab for the prevention and treatment of graft-versus-host disease
Publication
, Journal Article
Kanda, J; Lopez, RD; Rizzieri, DA
Published in: International Journal of Hematology
2011
Duke Scholars
Published In
International Journal of Hematology
EISSN
1865-3774
ISSN
0925-5710
Publication Date
2011
Start / End Page
1 / 8
Related Subject Headings
- Immunology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Kanda, J., Lopez, R. D., & Rizzieri, D. A. (2011). Alemtuzumab for the prevention and treatment of graft-versus-host disease. International Journal of Hematology, 1–8.
Kanda, J., R. D. Lopez, and D. A. Rizzieri. “Alemtuzumab for the prevention and treatment of graft-versus-host disease.” International Journal of Hematology, 2011, 1–8.
Kanda J, Lopez RD, Rizzieri DA. Alemtuzumab for the prevention and treatment of graft-versus-host disease. International Journal of Hematology. 2011;1–8.
Kanda, J., et al. “Alemtuzumab for the prevention and treatment of graft-versus-host disease.” International Journal of Hematology, 2011, pp. 1–8.
Kanda J, Lopez RD, Rizzieri DA. Alemtuzumab for the prevention and treatment of graft-versus-host disease. International Journal of Hematology. 2011;1–8.
Published In
International Journal of Hematology
EISSN
1865-3774
ISSN
0925-5710
Publication Date
2011
Start / End Page
1 / 8
Related Subject Headings
- Immunology
- 1102 Cardiorespiratory Medicine and Haematology